Operation treatment, radiotherapy, chemical medication, biological immunization therapy are four major treatment means of the cancer at present. 手术治疗、放射治疗、化学药物治疗、生物免疫治疗是目前癌症的四大治疗手段。
The mature of molecular biotechnology made it possible for people to design gene instead of remaking function protein, and to use the recombinant DNA techniques for gene therapy and DNA immunization therapy. 分子生物学技术的成熟使人们从设计改造功能蛋白转向设计基因,并尝试进行基因治疗和DNA免疫。
Recently, biological therapy for ovarian cancer including immunization therapy and gene therapy has been paid more attention as the fourth therapeutic patttern, and showed infinite prospect. 随着基础研究的不断深入,包括免疫治疗和基因治疗的卵巢癌生物治疗作为肿瘤治疗的第四种模式日益受到重视,成为传统手术治疗和化疗的有力补充,显现出极具潜力的发展前景。
Objective: To explore the drug choice of chinical immunization therapy in the Behcet's syndrome and the change of immunization target before and behind treatment. 目的:探讨白塞氏综合征(Behcetsyndrome,BS)临床免疫治疗的药物选择和疗效,以及治疗前后免疫指标的变化。
The results of active and passive immunization therapy demonstrated that SEB-M 23-immunized mice could resist SEB-N lethal challenge and mice were completely protected from SEB lethality by antisera from SEB-M 23-immunized mice. 主动免疫治疗和被动免疫治疗结果证明,SEB-M23蛋白免疫的小鼠能抵抗野生型SEB致死剂量的攻击,同时被动转移免疫小鼠的抗血清能保护接受致死剂量SEB-N的小鼠免于死亡。
Establishment of BALB/ C Mouse Model with Hp Infection and Experimental Research on Its Immunization Therapy BALB/C小鼠Hp感染胃炎动物模型的建立和免疫治疗实验研究
Cell immunization could be used obtaining mAbs recognizing tissue-specific antigens and which would be useful for the future research, diagnosis and therapy at proteinome period. 结论细胞免疫能够获得识别组织特异性抗原抗体,能够为后继实验研究、诊断和治疗打下基础。
Progress on Immunization Therapy of the Ovary Cancer 卵巢癌的免疫治疗进展
This immunization therapy group revealed marked better 1, 2, 3 years of survival rate even including the average survival period of the dead patients. 结果显示免疫治疗组与对照组1~3年生存率及死亡病例平均生存期均有显著差异。